Emerging biotherapies for inflammatory bowel disease

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.8, Iss.2, 2003-11, pp. : 339-347

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging Biologics in the Treatment of Inflammatory Bowel Disease: What is Around the Corner?

Current Drug Targets, Vol. 11, Iss. 2, 2010-02 ,pp. : 249-260

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging biotherapies for Sjögren's syndrome

By Tobón Gabriel J Saraux Alain Pers Jacques-Olivier Youinou Pierre

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 2, 2010-06 ,pp. : 269-282

Informa Healthcare

Access to resources Recommend Favorite

Inflammatory Bowel Disease in the Elderly

By > Pardi Darrell S.

Drugs & Aging, Vol. 27, Iss. 8, 2010-08 ,pp. : 617-624

Adis International

Access to resources Recommend Favorite

Macrophages in Inflammatory Bowel Disease

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 2, 2003-06 ,pp. : 155-160

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics and Inflammatory Bowel Disease

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 6, Iss. 3, 2008-09 ,pp. : 201-224

Bentham Science Publishers

Access to resources Recommend Favorite